# Forensic Dossier: Study Forensics: APJ agonist as pharmacological exercise mimetic

**Run ID:** `full27_study-forensics-030_Claude_Haiku_4bb816`  
**Task:** study-forensics-030 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T08:20:36.037548+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** preclinical_to_therapeutic_leap  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Haiku
**Winner:** Claude Haiku — **40.0/100** (margin: 0.0)
**Failure modes:** named_not_explained, unused_assumption, wrong_answer
**Forensic flags:** 2
**Consistency findings:** 6
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Haiku | 0.0/30 | 1.2/8 | 4.8/8 | 4.3/6 | 3.9/6 | 5.2/6 | 5.6/8 | 8.0/8 | 1.5/10 | 8.5/10 | **40.0/100** |

## Study Forensics Audit

### Claude Haiku

**Classification:** `overclaim` [x] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 100%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Extra Findings:** cautious_scope_control, none_or_minor, unsupported_generalization, correlation_as_causation

## Reasoning Integrity Audit

### Claude Haiku
**Classification:** Correct and well-supported
**Load-bearing steps:** 0 / 7

## Mechanism Analysis

### Claude Haiku
| Aspect | Status |
|--------|--------|
| Concept named | :white_check_mark: effect |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Haiku
Conclusion claims: 1
- Direct support: 0
- Indirect support: 1
- Unsupported: 0
- Contradicted: 0


## Forensic Flags

### Claude Haiku

- **[MAJOR]** `well_reasoned_wrong`: Wrong answer but structured reasoning — may have a subtle logic error
  - `final_answer`: "overclaim"
- **[MODERATE]** `ungrounded_mechanism`: Mechanism named/described but not connected to case-specific data
  - `(mechanism analysis)`: "effect"


## Evidence Map

### Claude Haiku

**Correctness:** 0.0/30
  - (+) `final_answer`: "overclaim"
    _Agent's answer for correctness check_
  - Note: No match (got: overclaim)

**Support Strength:** 1.2/8
  - (+) `final_answer`: "overclaim"
    _Conclusion grounded by reasoning chain_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 7
  - Note: Reasoning graph confirms conclusion grounding

**Structural Reasoning:** 4.8/8
  - (+) `steps[3]`: "Observed that the claim about 'exercise hormone system' activation is presented as established fact, but this is a mecha"
    _Most informative reasoning step_
  - Note: 7 reasoning steps
  - Note: Low step utility: 0/7 steps contribute

**Assumption Discipline:** 4.3/6
  - (+) `assumptions[0]`: "The study is preclinical (mouse models) based on the text describing 'obese and diabetic mice' and 'heart-failure model'"
    _Most substantive assumption_
  - (-) `assumptions[0]`: "The study is preclinical (mouse models) based on the text describing 'obese and diabetic mice' and 'heart-failure model'"
    _Declared but unused in reasoning_
  - Note: 5/5 substantive assumptions
  - Note: 1 unused assumption(s)

**Uncertainty Handling:** 3.9/6
  - (+) `uncertainties[2]`: "The specific design of the mouse studies (e.g., were there appropriate controls, dose-response curves, mechanistic valid"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.78"
    _Stated confidence level_
  - Note: 5 uncertainties (5 substantive)
  - Note: Confidence 0.78

**Alternative Hypothesis Quality:** 5.2/6
  - (+) `alternative_hypotheses[0]`: "The study could be solid if interpreted as a preclinical proof-of-concept with appropriate caveats about translational l"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 1/2 include rejection reasoning

**Self Monitoring Quality:** 5.6/8
  - (+) `self_check[2]`: "Did I correctly identify the mechanism_vs_evidence issue? Yes—the company is claiming exercise mimicry (a human function"
    _Most substantive self-verification step_
  - Note: 5 self-check items
  - Note: Self-check quality: 0 deep, 5 arithmetic, 0 fluff

**Mechanism Quality:** 1.5/10
  - Note: Names concept but does not describe mechanism

**Communication Efficiency:** 8.5/10
  - Note: Signal density: 0.68, 576 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Haiku

**CRITICAL:**
- **Wrong Answer** `[HIGH CONFIDENCE]`: Answer does not match expected 'mechanism_vs_evidence'
  - `final_answer`: "overclaim"
  - _Impacts: correctness_

**MAJOR:**
- **Wrong Answer** `[HIGH CONFIDENCE]`: Study classification incorrect: expected 'mechanism_vs_evidence', detected 'overclaim'
  - `final_answer`: "overclaim"
  - _Impacts: correctness_

**MODERATE:**
- **Named Not Explained** `[MEDIUM CONFIDENCE]`: Names the phenomenon but does not explain the causal mechanism
  - `final_answer`: "overclaim"
  - _Impacts: mechanism_quality_
- **Named Not Explained** `[MEDIUM CONFIDENCE]`: Named concept(s) ['effect'] but mechanism not described
  - _Impacts: mechanism_quality, insight_depth_

**STYLISTIC:**
- **Unused Assumption** `[HEURISTIC]`: Assumption 'The study is preclinical (mouse models) based on the text de...' is declared but not referenced in reasoning
  - `assumptions[0]`: "The study is preclinical (mouse models) based on the text describing 'obese and diabetic mice' and '"
  - _Impacts: assumption_discipline_


## Consistency & Grounding Audit

### Claude Haiku

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (1/16 content words)
  - `key_claims[0]`: "The primary overclaim is translating mouse efficacy directly to human therapeutic potential without "
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/16 content words)
  - `key_claims[1]`: "The 'exercise hormone' framing is mechanistic interpretation (pathway activation) presented as estab"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (1/23 content words)
  - `key_claims[2]`: "Combining results from multiple mouse models (obesity, diabetes, heart failure) to support a single "
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/13 content words)
  - `key_claims[3]`: "The statement that the company is 'preparing to translate' suggests confidence in human efficacy bas"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "This could be mechanism_vs_evidence if the company is claiming the drug works via 'exercise mimicry'"
- **[NOTE]** `[MEDIUM CONFIDENCE]` `mechanism_gap`: Causal mechanism described but underlying concept not named
  - `final_answer`: "overclaim"


## Agent Profiles

### Claude Haiku (claude-haiku-4-5-20251001)
**Parse OK:** True | **Latency:** 12895ms

**Final Answer:** overclaim

**Confidence:** 0.78

**Assumptions:**
- The study is preclinical (mouse models) based on the text describing 'obese and diabetic mice' and 'heart-failure model'
- The company is making claims about human therapeutic potential based on animal data
- The results reported are accurate as stated
- No human efficacy or safety data are presented
- The 'exercise hormone' framing is the company's characterization, not necessarily established biology

**Reasoning Steps:**
1. Identified that all evidence is from mouse models (obese/diabetic mice, heart-failure model)
2. Noted the company claims the drug 'could serve as a pharmacological exercise mimetic' and is 'preparing to translate' to human trials
3. Recognized that mouse models of obesity, diabetes, and heart failure have poor predictive validity for human efficacy (well-documented translational gap)
4. Observed that the claim about 'exercise hormone system' activation is presented as established fact, but this is a mechanistic interpretation of pathway activation, not direct evidence of exercise mimicry in humans
5. Noted that combining with incretin therapy shows synergy in mice, but this doesn't establish that the same combination will work in humans or that the mechanism is the same
6. Identified that preservation of muscle mass while losing weight is claimed but not contextualized against known challenges in human weight loss (sarcopenia is common)
7. Checked for uncertainty language: the text uses 'could serve as' (appropriate hedging) but the overall framing treats mouse results as sufficient justification for human translation

**Key Claims:**
- The primary overclaim is translating mouse efficacy directly to human therapeutic potential without acknowledging the well-known translational gap for obesity and diabetes models
- The 'exercise hormone' framing is mechanistic interpretation (pathway activation) presented as established fact, not evidence that the drug produces exercise-like effects in humans
- Combining results from multiple mouse models (obesity, diabetes, heart failure) to support a single broad claim about 'pharmacological exercise mimetic' is a form of generalization beyond what each model individually supports
- The statement that the company is 'preparing to translate' suggests confidence in human efficacy based on preclinical data alone, which is premature

**Alternative Hypotheses:**
- The study could be solid if interpreted as a preclinical proof-of-concept with appropriate caveats about translational limitations—but the text presents it as justification for human trials without acknowledging the mouse-to-human gap
- This could be mechanism_vs_evidence if the company is claiming the drug works via 'exercise mimicry' in humans based on pathway activation in mice, without evidence that the pathway produces exercise-like effects in humans

**Uncertainties:**
- Whether the original peer-reviewed publication (if one exists) contains appropriate caveats that are absent from this summary
- Whether the company's internal documents acknowledge translational limitations or present this as definitive evidence
- The specific design of the mouse studies (e.g., were there appropriate controls, dose-response curves, mechanistic validation?)
- Whether 'nearly doubled weight loss' is compared to vehicle control or to the incretin therapy alone
- The magnitude of HbA1c reduction and whether it's clinically meaningful in the mouse model

**Self-Verification:**
- Did I overstate the problems? No—the mouse-to-human translational gap is a genuine, well-documented issue in obesity/diabetes research, not a fabricated concern
- Did I miss that this might be a solid preclinical study? The study itself may be well-designed, but the CLAIMS made about human translation exceed the evidence
- Did I correctly identify the mechanism_vs_evidence issue? Yes—the company is claiming exercise mimicry (a human functional outcome) based on pathway activation in mice (a mechanistic finding)
- Is the overclaim label appropriate? Yes—the text moves from mouse data to human therapeutic claims without acknowledging limitations
- Did I check for confounders in the mouse studies? I noted I cannot assess this from the summary, which is appropriate epistemic humility

**Dimension Scores:**
- Correctness: 0.0/30 `..........`
- Support Strength: 1.2/8 `#.........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.3/6 `#######...`
- Uncertainty Handling: 3.9/6 `######....`
- Alternative Hypothesis Quality: 5.2/6 `########..`
- Self Monitoring Quality: 5.6/8 `#######...`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 1.5/10 `#.........`
- Communication Efficiency: 8.5/10 `########..`


## Final Verdict

**Solo run: Claude Haiku** scored **40.0/100**.

**Best per dimension:**
- Correctness: Claude Haiku (0.0/30)
- Support Strength: Claude Haiku (1.2/8)
- Structural Reasoning: Claude Haiku (4.8/8)
- Assumption Discipline: Claude Haiku (4.3/6)
- Uncertainty Handling: Claude Haiku (3.9/6)
- Alternative Hypothesis Quality: Claude Haiku (5.2/6)
- Self Monitoring Quality: Claude Haiku (5.6/8)
- Insight Depth: Claude Haiku (8.0/8)
- Mechanism Quality: Claude Haiku (1.5/10)
- Communication Efficiency: Claude Haiku (8.5/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Haiku | 12.9s | 40.0/100 | 3.1 |

Failure modes observed: named_not_explained, unused_assumption, wrong_answer.
